Trial Profile
A comparative study of prasugrel and clopidogrel in percutaneous coronary intervention (PCI) for acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 06 Oct 2016 New trial record